Brighter

About:

Brighter is a technology and innovative services provider for the treatment of chronic conditions.

Website: http://brighter.se

Twitter/X: brighterinnov

Top Investors: Formue Nord

Description:

Data-driven solutions for smarter treatment of chronic conditions. Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Tackling diabetes first. Brighter is currently focused on treating the global diabetes epidemic by launching Actiste® Diabetes Management as a Service. https://actiste.com/ The Actiste device is based on patented technology for the remote monitoring and collection of data on specified bio-markers and volumes of medication injected. We believe this data-centric approach is key to providing smarter care for both diabetes and other chronic conditions too. Why Actiste? A video explaining the diabetes care service Actiste: https://youtu.be/qLWfTUbl3eM Brighter’s business model includes out-licensed rights to its platform. A business-critical part of Brighter’s operations involves continuous IP portfolio development—via its own applications and in-licensing (for example, the micro-needle technology in-licensing that Brighter acquired for blood sugar monitoring).